10/30/2024
6:33 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:06 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:08 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:54 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:28 PM | Summit Therapeutics (Filer)
| Form S-3ASR | |
09/13/2024
6:29 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:25 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/13/2024
4:54 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024
4:40 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:26 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:29 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:49 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:23 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:14 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:37 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2024
4:20 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:16 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
3:27 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:14 PM | Summit Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/17/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
1:03 PM | Summit Therapeutics (Filer)
| Form DEFA14A | |
06/03/2024
5:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
3:48 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:35 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:03 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:48 AM | Summit Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
7:45 AM | Summit Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:11 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
8:21 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
8:19 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
3:35 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:52 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
4:43 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:47 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:42 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
7:27 PM | Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:28 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
7:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:36 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
I want to send you my Cash Calendar (Ad) This Calendar reveals the EXACT dates that — if everything goes right — anyone can target cash payouts of $125, $415, and even $1,665.
(With just a $1,000 starting stake!)
Granted, there were smaller wins and those that did not work out and we cannot promise future returns or against losses, but these payouts don’t require any special knowledge or skills.
Anyone can set them up with just three clicks in their brokerage account.
And the money can be deposited in their account the very next morning after opening the trade.
Again, I want to send this Cash Calendar to you completely FREE.
All you have to do is join me for my free Cash Calendar training right here.
You don’t want to miss this. There is a very special bonus surprise for everyone who attends.  Reserve your seat. |
02/27/2024
11:15 PM | Summit Therapeutics (Filer)
| Form EFFECT | |
02/20/2024
6:55 AM | Summit Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/20/2024
7:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:32 AM | Summit Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:35 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/08/2024
3:08 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:19 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:24 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:16 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
